Molly R. Ryan

Discovery, Synthesis, and Molecular Pharmacology of Selective Positive Allosteric Modulators of the δ-Opioid Receptor

Neil T. Burford, Kathryn E. Livingston, Meritxell Canals et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles’ Heel of Targeted Therapy

Christal D. Sohl, Molly R. Ryan, BeiBei Luo et al. · ACS Chemical Biology · 2015 · 70 citations

Medicine, Cancer Biology, Oncology +17

The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT

Molly R. Ryan, Christal D. Sohl, BeiBei Luo et al. · Molecular Cancer Research · 2018 · 56 citations · Full text

Medicine, Oncology, Pharmacology +16

MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma

Alex Panaccione, Yi Zhang, Molly R. Ryan et al. · Stem Cell Research · 2017 · 26 citations · Full text

Medicine, Cell Biology, Oncology +15

AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich’s ataxia

Joshua C. Chang, Molly R. Ryan, Marie C. Stark et al. · Molecular Therapy — Methods & Clinical Development · 2024 · 16 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16